new med for type 2 diabetes, Avandia (rosiglitazone)

You'll see a new med for type 2 diabetes, Avandia (rosiglitazone).

It's a new "glitazone"...similar to Rezulin (troglitazone). A third one, Actos (pioglitazone) will be out later this summer.

These new drugs come at a good time...with all the concern about hepatotoxicity from Rezulin.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote